Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Shares Outstanding: 2023-2024

Historic Shares Outstanding for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to $76.2 million.

  • CG Oncology's Shares Outstanding rose 15.90% to $78.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $78.3 million, marking a year-over-year increase of 15.90%. This contributed to the annual value of $76.2 million for FY2024, which is 1358.27% up from last year.
  • According to the latest figures from FY2024, CG Oncology's Shares Outstanding is $76.2 million, which was up 1,358.27% from $5.2 million recorded in FY2023.
  • In the past 5 years, CG Oncology's Shares Outstanding registered a high of $76.2 million during FY2024, and its lowest value of $5.2 million during FY2023.
  • For the 2-year period, CG Oncology's Shares Outstanding averaged around $40.7 million, with its median value being $40.7 million (2023).
  • Data for CG Oncology's Shares Outstanding shows a peak YoY surged of 1,358.27% (in 2024) over the last 5 years.
  • Over the past 2 years, CG Oncology's Shares Outstanding (Yearly) stood at $5.2 million in 2023, then soared by 1,358.27% to $76.2 million in 2024.